Applied DNA’s Molecular Tagging Technology to Ensure Authenticity of Egyptian Cotton
May 02 2019 - 4:30AM
Business Wire
SigNature® T Traceability System to be
Installed in Egypt to Tag Two Cotton Varietals
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the
“Company”), a leader in PCR-based manufacturing for product
authenticity and traceability solutions, announced today it
received an order for the implementation of its SigNature® T cotton
traceability system in Egypt to indelibly mark two varietals of
high-value Egyptian cotton, widely acknowledged to be among the
finest in the world. The molecular tag and delivery system have
been shipped and cotton tagging is expected to commence within the
month. The system, already installed in eight cotton gins
worldwide, includes the use of unique SigNature T molecular tags,
internet-based data collection linking evidence of tagging process
quality to each bale ID, and bar code scanning of tagged packaged
bales for inventory management and tracking. The cotton fiber will
be managed with strict protocols throughout the supply chain to
ensure purity and traceability.
“With receipt of this order for Egyptian cotton supply chain
tagging and testing, we are moving to replicate our success in
securing U.S. cotton through its supply chain. Given the
uncertainty surrounding the provenance of Egyptian cotton in the
marketplace and growing calls for increased transparency and
traceability by consumers, brands and industry advocates, the
implementation of our SigNature T cotton traceability system
endeavors to ensure that the value of Egyptian cotton can be
substantiated throughout its supply chain,” said Dr. James A.
Hayward, president and CEO of Applied DNA.
According to the Mundi Report, Egypt produced approximately 240
million pounds of cotton in the prior 2018 growing season, just
below total U.S. Pima output.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit www.adnas.com for more information. Follow us on Twitter
and LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of
1995. Forward-looking statements describe Applied DNA’s
future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and
uncertainties, many of which are beyond the control of Applied DNA.
Actual results could differ materially from those projected due to
our history of net losses, limited financial resources, limited
market acceptance, and various other factors detailed from time to
time in Applied DNA’s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 18, 2018 and our subsequent
quarterly report on Form 10-Q filed on February 7, 2019, and other
reports we file with the SEC, which are available
at www.sec.gov. Applied DNA undertakes no obligation to update
publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events, unless otherwise
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190502005237/en/
investor contact: Sanjay M. Hurry, LHA Investor
Relations, 212-838-3777, shurry@lhai.commedia
contact: Meryl Rader, 781-639-4924,
meryl@cgprpublicrelations.comprogram contact: MeiLin Wan,
Vice President of Sales, 631-240-8849,
meilin.wan@adas.comweb: www.adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024